Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
442.85
10.33 (2.39%)
At close: Aug 14, 2025, 3:59 PM
442.73
-0.03%
Pre-market: Aug 15, 2025, 08:45 AM EDT
Alnylam Pharmaceuticals Revenue
Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending June 30, 2025, Alnylam Pharmaceuticals generated $773.69M in revenue.
Revenue (ttm)
2.25B
Revenue Growth
22.97%
Price / Sales Ratio
13.36
Revenue / Employee
1.01M
Employees
2,230
Market Cap
58.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|